Zobrazeno 1 - 10 of 53 pro vyhledávání: '"J Kottakis"'
1
Akademický článek
Similar Bronchodilation with Formoterol Delivered by Aerolizer or Turbuhaler
Autor: J Lötvall, A Mellén, P Arvidsson, M Palmqvist, P Radielovic, J Kottakis, P Pfister
Publikováno v: Canadian Respiratory Journal, Vol 6, Iss 5, Pp 412-416 (1999)
BACKGROUND: In many countries, two dry powder formulations of inhaled formoterol are available for clinical use; one uses a single-dose device (Foradil, Aerolizer), and the other uses a multiple-dose device (Oxis, Turbuhaler).
Externí odkaz: https://doaj.org/article/e1430a6091cb47b49932345a45924e6c
Zobrazit plný text záznamu
2
Akademický článek
O formoterol e uma dose média/ elevada de corticosteróides inalados são mais eficazes do que uma dose elevada de corticosteróides na asma moderada e grave
Autor: G. Mitchell, C. Jenkins, R. Scicchitano, R.A. Dubinfeld, J. Kottakis
Publikováno v: Revista Portuguesa de Pneumologia, Vol 10, Iss 5, Pp 448-450 (2004)
RESUMO: As normas internacionais para o tratamento da asma brônquica recomendam que os doentes com sintomatologia mal controlada com doses baixas/ /intermédias de corticosteróides (CT) inalados sejam submetidos a doses mais elevadas de CT e,
Externí odkaz: https://doaj.org/article/35946210e64548bab637bc5adad3933b
Zobrazit plný text záznamu
3
Akademický článek
O formoterol e uma dose média/ elevada de corticosteróides inalados são mais eficazes do que uma dose elevada de corticosteróides na asma moderada e grave
Autor: G. Mitchell, C. Jenkins, R. Scicchitano, A. Dubinfeld, J. Kottakis
Publikováno v: Revista Portuguesa de Pneumologia, Vol 9, Iss 3, Pp 448-450 (2003)
RESUMO: As normas internacionais para o tratamento da asma brônquica recomendam que os doentes com sintomatologia mal controlada com doses baixas/ /intermédias de corticosteróides (CT) inalados sejam submetidos a doses mais elevadas de CT e,
Externí odkaz: https://doaj.org/article/5adea7ff9b0d4819b089b5ab2b24d2e0
Zobrazit plný text záznamu
6
Similar Bronchodilation with Formoterol Delivered by Aerolizer or Turbuhaler
Autor: P Arvidsson, P Pfister, Mona Palmqvist, P Radielovic, Anders Mellén, J Kottakis, Jan Lötvall
Publikováno v: Europe PubMed Central
Canadian Respiratory Journal, Vol 6, Iss 5, Pp 412-416 (1999)
BACKGROUND: In many countries, two dry powder formulations of inhaled formoterol are available for clinical use; one uses a single-dose device (Foradil, Aerolizer), and the other uses a multiple-dose device (Oxis, Turbuhaler).OBJECTIVES: To study the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4567b6ca2cc8ac6a2457352175ae7fb6
https://doi.org/10.1155/1999/193245
Zobrazit plný text záznamu
7
O formoterol e uma dose média/ elevada de corticosteróides inalados são mais eficazes do que uma dose elevada de corticosteróides na asma moderada e grave
Autor: Christine Jenkins, G. Mitchell, J. Kottakis, R. Scicchitano, A. Dubinfeld
Publikováno v: Revista Portuguesa de Pneumologia, Vol 10, Iss 5, Pp 448-450 (2004)
Revista Portuguesa de Pneumologia, Vol 9, Iss 3, Pp 448-450 (2003)
RESUMO: As normas internacionais para o tratamento da asma brônquica recomendam que os doentes com sintomatologia mal controlada com doses baixas/ /intermédias de corticosteróides (CT) inalados sejam submetidos a doses mais elevadas de CT e,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bf4fba9e435dccbeec57090fdf2a26d
Zobrazit plný text záznamu
8
FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer in chronic obstructive pulmonary disease
Autor: J F, Muir, D, Benhamou, A, Cuvelier, V, Le Gros, T, Overend, D, Till, G, Della Cioppa, J, Kottakis
Publikováno v: International journal of clinical practice. 58(5)
Evaluation of patients with chronic obstructive pulmonary disease (COPD) often includes the use of post-bronchodilator reversibility testing to guide treatment decisions. Recommendations for reversibility testing differ and there is no universally ac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0941aa0c0d6e78491b96e5951a01acd3
https://pubmed.ncbi.nlm.nih.gov/15206501
Zobrazit plný text záznamu
9
Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma
Autor: J. Kottakis, Charles Mitchell, A. Rubinfeld, R. Scicchitano, Christine Jenkins
Publikováno v: Pulmonary pharmacologytherapeutics. 16(5)
This double-blind, randomised, multi-centre, parallel-group study compared the effect of adding Foradil (formoterol fumarate) to existing medium-high doses of inhaled corticosteroids (ICS) with that of doubling the dose of ICS in patients with sub-op
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88d31703151bd09e35a2842e326e7f3
https://pubmed.ncbi.nlm.nih.gov/12877821
Zobrazit plný text záznamu
10
Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma
Autor: R, Dahl, J P, Creemers, J, Van Noord, A, Sips, G, Della Cioppa, M, Thomson, K, Andriano, J, Kottakis, T, Fashola
Publikováno v: Respiration; international review of thoracic diseases. 71(2)
For maximum treatment compliance there is a need to provide asthma patients with devices that suit their particular preferences. The Foradil Certihaler is a novel multi-dose dry powder inhaler developed to increase the choice of devices available.To
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d243188ff8b95b085e42d2e7ebfa3b1f
https://pubmed.ncbi.nlm.nih.gov/15031566
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje